Replies to post #385898 on Elite Pharmaceuticals Inc (ELTP)

[kayak_wench]

He doesn't believe PRs make a difference in stock price and explicitly stated he isn't going to PR something to move the stock price in just this last CC. If he feels it a PR will negatively affect Elite's long-term financials (for instance by giving heads up to competitors on when to time their contract renewal to make it difficult for Elite to get contracts with a new product) he isn't going to do it like he didn't do it with the insufflation study. If a competitor has less than a year in a contract they have less opportunity to mess with Elite's access to new customers.
Letting the cat out of the bag more than a year out can let competitors address the additional competition in the next renewal. He talked about this being a problem with the Adderall ER rollout.

From last CC

When we issue, profound press releases, about great achievements of the Company's financials and moving to profitability and contracts with other companies, all the great stuff that we have done in the past five years when we've been every year creating more revenues and more profit than the year before. When we do all of that and the stock doesn't even move.